Publicaciones en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (17)

2023

  1. Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma

    Haematologica, Vol. 108, Núm. 1, pp. 110-121

2021

  1. Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

    Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491

2020

  1. Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study

    British Journal of Haematology, Vol. 188, Núm. 5, pp. 745-756

2019

  1. Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

    Bone Marrow Transplantation, Vol. 54, Núm. 10, pp. 1625-1631

2018

  1. GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus

    Medicina Clinica, Vol. 151, Núm. 1, pp. 39.e1-39.e17

  2. Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant

    Annals of Internal Medicine, Vol. 169, Núm. 10, pp. 674-683

2017

  1. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

  2. Single umbilical cord blood with or without CD341 cells from a third-party donor in adults with leukemia

    Blood Advances, Vol. 1, Núm. 15, pp. 1047-1055

2013

  1. Stem cell mobilization in HIV seropositive patients with lymphoma

    Haematologica, Vol. 98, Núm. 11, pp. 1762-1768

2012

  1. Human immunodeficiency virus-associated plasmablastic lymphoma: Poor prognosis in the era of highly active antiretroviral therapy

    Cancer, Vol. 118, Núm. 21, pp. 5270-5277

2011

  1. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: A multicenter study

    American Journal of Hematology, Vol. 86, Núm. 3, pp. 256-261

2010

  1. Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis and Study of the Impact of Hematopoietic Graft Source

    Biology of Blood and Marrow Transplantation, Vol. 16, Núm. 7, pp. 957-966

2009

  1. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation

    Blood, Vol. 113, Núm. 23, pp. 6011-6014

2008

  1. Antithymocyte globulin therapy for steroid-resistant acute graft versus host disease

    American Journal of Hematology

  2. Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y el tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana

    Medicina Clinica

2005

  1. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation

    Experimental Hematology, Vol. 33, Núm. 4, pp. 487-494

2002

  1. GESIDA/PETHEMA guidelines for the diagnosis and treatment of lymphomas in HIV-infected patients

    Medicina Clinica